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Abstract
Background: Medical decision-making is critical to patient survival and well-being. Patients with end stage renal
disease (ESRD) are faced with incrementally complex decision-making throughout their treatment journey. The
extent to which patients seek involvement in the decision-making process and factors which influence these in
ESRD need to be understood.
Methods: 535 ESRD patients were enrolled into the cross-sectional study arm and 30 patients who started dialysis
were prospectively evaluated. Patients were enrolled into 3 groups- ‘predialysis’ (group A), ‘in-centre’ haemodialysis
(HD) (group B) and self-care HD (93 % at home-group C) from across five tertiary UK renal centres. The Autonomy
Preference Index (API) has been employed to study patient preferences for information-seeking (IS) and decision-making
(DM). Demographic, psychosocial and neuropsychometric assessments are considered for analyses.
Results: 458 complete responses were available. API items have high internal consistency in the study population
(Cronbach’s alpha > 0.70). Overall and across individual study groups, the scores for information-seeking and
decision-making are significantly different indicating that although patients had a strong preference to be well
informed, they were more neutral in their preference to participate in DM (p < 0.05). In the age, education and
study group adjusted multiple linear regression analysis, lower age, female gender, marital status; higher API IS
scores and white ethnicity background were significant predictors of preference for decision-making. DM scores
were subdivided into tertiles to identify variables associated with high (DM > 70: and low DM (≤30) scores. This
shows association of higher DM scores with lower age, lower comorbidity index score, higher executive brain
function, belonging in the self-caring cohort and being unemployed. In the prospectively studied cohort of
predialysis patients, there was no change in decision-making preference scores after commencement of dialysis.
Conclusion: ESRD patients prefer to receive information, but this does not always imply active involvement in
decision-making. By understanding modifiable and non-modifiable factors which affect patient preferences for
involvement in healthcare decision-making, health professionals may acknowledge the need to accommodate
individual patient preferences to the extent determined by the individual patient factors.
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Background
‘Nothing is more difficult, and therefore more precious,
than to be able to decide’
Napoleon Bonaparte
Medical decision-making is critical to patient sur-
vival and well-being[1]. Over the last two decades, the
convergence of influential ideas from the fields of bio-
ethics, psychology, sociology and medicine has con-
tributed to our understanding of the beneficial role of
engaging patients in the medical decision-making
process. The several potential benefits of involving pa-
tients in medical decision-making (DM) include re-
duced anxiety and depression, greater self-efficacy,
improved concordance, and higher satisfaction with
their physician [2–6]. Patient’s expectations about ex-
ercising choice in medical decision-making have also
been influenced by socio-cultural factors. These stem
from increasing consumerist attitudes and litigious
practices in the society, leading to the belief amongst
healthcare professionals, that patients are best placed
to evaluate the risks and benefits of alternative treat-
ments [7], [8]. Of the models of healthcare decision-
making that exist, an extreme and impractical version
of the ‘patient engagement model’ of healthcare in
practice would result in the providers supplying accur-
ate information to patients without sharing their own
views or experiences and then expecting patients to
make tough medical decisions on their own. Research
has demonstrated that patients’ desire for information
is typically underestimated by physicians[6]. What is
less apparent is the extent to which they seek involve-
ment in the actual decision-making process.
Healthcare decision-making is a highly complex
process, the outcome of which is the interplay of sev-
eral interrelated factors[7, 9, 10] and not limited only
to uncertainty in scientific evidence. As decision-
making is affected by several factors, it is prone to
error[1]. It is not surprising therefore, as to why some
patient decisions may be at odds with the healthcare
provider recommendations, making even shared deci-
sions difficult to implement in clinical practice.
In several clinical conditions, evidence shows that not
all patients want to make their own decisions[6] and
some would actively delegate the task to their healthcare
professionals. This concept has not been well under-
stood in chronic kidney disease (CKD). Patients with
CKD are faced with incrementally complex decision-
making throughout their treatment journey. Particularly
in later stages, patients exercise choice and make deci-
sions which impact on how they live from day to day.
Some of these include decisions around dietary intake,
medications, frequency of clinic visits, treatment options
when they reach end stage renal disease (ESRD) and
even the choice of not considering renal replacement
therapy. Dialysis, a life-sustaining therapy, invites mul-
tiple levels of patient engagement with and without
healthcare providers, making it an intellectually and
emotionally demanding process. Accommodating indi-
vidual patient preferences for participation and true
shared decision-making as the ‘ideal’ may be in potential
conflict in some instances.
‘Autonomy’ in decision-making is one of several fac-
tors which may influence healthcare decisions through-
out the ESRD journey. We chose to study this construct
to understand its basis in undertaking self-care in the
ESRD context. Decisions are taken based on the infor-
mation patients acquire from healthcare providers and
other sources. Also, the impact of ‘real’ vs ‘imaginary’
knowledge may influence patient attitudes to decision-
making. Patients with ESRD are expected to assimilate a
lot of new information in a particularly vulnerable phase
of their illness, sometimes with limitations in cognitive
and computational skills [11] and in relatively short time
frames, leading to critical, life-changing decisions. Mul-
tiple inter-related skills are required to function opti-
mally and produce the best outcomes for the individual
circumstance. These include the ability to access and
comprehend information, recall the same, weigh alterna-
tives, infer and communicate decisions effectively and
engage in a life-long process of learning [12, 13]. All of
these activities are a product of complex processing of
information in the brain of individuals. Executive brain
function is a higher order cognitive ability that is a prod-
uct of working memory, reasoning, task flexibility and
visuo-motor speed. It is well known that chronic kidney
disease is associated with considerable executive and epi-
sodic memory cognitive deficit, which is also progressively
on the decline, after commencement of haemodialysis [11].
The reported prevalence of cognitive deficit in dialysis pa-
tients is of the order of 17-50 % [14]. Closely related to sys-
tematic, careful cognitive processing is the role of the
patient’s ‘affect’ on decision-making. Understanding ESRD
healthcare decision-making from a psychological perspec-
tive is paramount due to the high prevalence of depression
or anxiety amongst these patients (up to 70 %) [15, 16].
Study objectives
Although ‘autonomy’ and ‘decision-making’ are not syn-
onymous with each other, in contemporary medical
literature, the two have been used interchangeably[24].
In the present study, ‘information-seeking’ and ‘decision-
making’ preferences are evaluated in a large group of
ESRD patients.
We sought to
1) Describe the properties of Autonomy Preference
Index (API) instrument in ESRD population.
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2) Examine clinical, psychological and neurocognitive
correlates of ‘autonomous decision-makers’ vs
‘delegators’ in ESRD.
3) Study the impact of commencement of dialysis on
decision-making, in a subset of predialysis patients.
Methods
The API study data are derived from data ascertained
for the BASIC-HHD study[18]. The BASIC-HHD study
is a comprehensive and systematic study of barriers and
enablers of the uptake and maintenance of home HD
therapy. The study involves five UK centres, with vari-
able prevalence rates of home HD. The centres reported
similar structure of pre-dialysis education programmes
with access to nurse specialists for information and dedi-
cated ‘low-clearance’ clinics. An integrated mixed meth-
odology (convergent, parallel design) has been adopted
for the BASIC-HHD study in a combined cross-sectional
and prospective study design. The methodological details
and scope of data collected in the BASIC-HHD appear
in a published protocol[18].
Study registration
This study has been reviewed and approved by the Greater
Manchester West Health Research Authority National
Research Ethics Service (NRES) Reference number: 12/
NW/0170. The study is on the NIHR portfolio (ID 12346).
Written, informed consent from participants was obtained
for the study
Participants
Data presented here are derived from the cross-sectional
and prospective segments of the BASIC-HHD study. 535
patients were enrolled in three groups. Predialysis pa-
tients for the CKD-5 group (group A), prevalent ‘in-
centre’ HD patients (group B) were approached if they
fulfilled eligibility criteria and were willing to undertake
neuropsychometric assessments and complete study
specific questionnaires. All self-care haemodialysis pa-
tients (93 % at home) from each participating centre
were also approached (group C). Predialysis patients
were approached consecutively from the predialysis clinics
and hospital haemodialysis patients were approached in
consecutive order across all shifts until the centre target for
recruitment was reached. Most participants approached
were willing to engage with the study and reasons for de-
clining participation included a lack of interest in research
participation, and ‘research’ fatigue.
Procedure
Psychological measures employed in this study were a
part of compilation of questionnaires. Blood sampling
and neuropsychometric assessments were carried out
ahead of the dialysis sessions. HD patients returned the
questionnaires on the same day or within a couple of
dialysis sessions ‘in-centre’. Home HD patients returned
it by post, as did the pre-dialysis patients. Visually im-
paired patients could respond to questions posed to
them by the research team member.
Measures
The Autonomy Preference Index was used to study pa-
tient preferences for information-seeking and decision-
making. This tool was developed and validated originally
in a group of general medical patients [17]. This tool
consists of two subscales: an eight-item information-
seeking subscale and a six-item decision-making sub-
scale. The format of the responses is on a 5-point Likert
scale. Scores for both domains are linearized to range
from 0–100 (percentage scores), with higher scores indi-
cating stronger preferences for participation. In addition,
in the original API there are eight items corresponding
to three clinical vignettes representing increasing disease
severity to assess if symptom severity plays a role in pa-
tient autonomy preferences. The API has been validated
and utilized in numerous other patient populations. The
tool was employed; unmodified, as the questions and
clinical scenarios are both relevant and not unfamiliar to
the ESRD population.
Additionally, all study participants completed a compil-
ation of questionnaires[18]. In order to examine the poten-
tial impact of patient’s affect and cognitive ability on their
engagement with decision-making, additional instruments
analysed in the present study are the Beck Depression
Inventory II[19] and the State and Trait Anxiety Inven-
tory[20]. Participants underwent cognitive assessment using
the modified mini-mental state examination (3MS)[21], and
trail making tests A and B (TMTA/TMTB) scores[22]. The
scores from these instruments were considered in ordered
categories for analyses: BDI (0–10, 11–15, 16–20, 21–25,
26–30, 31+), STAI (20–29, 30–39, 40–49, 50+) and 3MS
(94–100, 86–93, 81–85, 76–80, ≤75).
Missing data
Overall the study had excellent data completion across
all instruments used in the study (>82 %). The API sub-
scales were complete in 85.6 % of the cases (Fig. 1). The
only statistically significant difference between those
who were missing both the API decision-making and
API information-seeking scores (n = 77) and those who
were not missing both is in ethnicity. Non-white patients
were more likely not to complete both API scores than
white patients. Ethnicity was associated with decision
making in the final multivariable analysis for the deci-
sion making variable. Therefore, there is a chance that
the point estimate may change slightly, depending on
whether the non-white patients who responded had dif-
ferent scores to those who did not respond. However,
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with the relatively small amount of missing data and
only 15 non-white patients not having either score, any
change would be small. There was no relationship in the
single variable analysis between ethnicity and information
seeking so unless the missing non-white patients differed
greatly to the non-white patients who responded, it is
likely the lack of association would remain (see Additional
file 1: supplementary information).
Statistical analyses
All analyses were carried out using SPSS 20. Patient charac-
teristics between groups were compared using ANOVAs,
chi-square tests and Kruskal-Wallis tests using conven-
tional two-sided 5 % significance level. Appropriate adjust-
ments – Scheffé adjustments for pairwise differences in
ANOVA, Bonferroni adjustments in z-tests of category pro-
portions and Mann–Whitney U tests – were made to ac-
count for multiple testing when carrying out pairwise
comparisons. Cronbach’s alpha was used to assess the in-
ternal consistency of the two API subscales in the ESRD
group. A confounder-adjusted analysis has been carried out
for all variables considered in the study in accordance with
the definition of a potential confounder[23]. Variables from
this analysis were also used to inform the choice of vari-
ables in the multivariable regression model. The multivari-
able linear regression with a backwards step-wise selection
method was used to identify the variables that are associ-
ated with the API decision-making preference of patients.
The same selection method was used for API information
seeking. Variables with p-value of less than 0.15 in the
single variable analysis were considered for selection in
the multivariable analysis. In the multivariable analysis,
three variables were considered clinically important: age,
education and group. The other variables were removed
from the model until only those with a p-value less than
0.05 remained. A linear mixed effects model with centre
as the random effect has been used to account for a pos-
sible centre effect .The ICC (intraclass correlation coeffi-
cient) is the measure of the ratio of the between cluster
variance to the total variance (between-cluster + within-
cluster). ICC close to 1 indicates the people in the cluster
are very similar, whereas ICC close to 0 indicates the
between-cluster variability is small compared to the
within-cluster variability. Three patient subgroups, based
on the API decision-making scores were also constructed,
to understand factors associated with these scores in the
highest and lowest tertiles. The patient subgroup charac-
teristics were examined using Mann–Whitney U tests,
Fisher’s exact tests and linear-by-linear chi-square tests.
Paired t-tests were used to examine change over time for
the prospective data from 30 Group ‘A’ (CKD-5) patients.
Results
Demographic and clinical characteristics of the ESRD
population
A total of 458 responses were available. 39.7 % of the re-
sponses came from predialysis patients. Overall, patients re-
ceiving home HD were younger, more educated and in
employment. They had the support of care-givers at home,
predominantly, spouses. There were significantly greater
numbers of patients with diabetes and greater comorbidity
burden in the ‘predialysis’ and ‘in-centre’ dialysis groups.
There was no significant difference between groups with re-
spect to previously diagnosed affective disorders or in their
screening for anxiety and depression using validated inven-
tories. These group comparisons are important to adjust
later analyses for potential confounders. The differences be-
tween the groups are illustrated in Table 1. Due to clinical
Fig. 1 Diagram depicting API data available for analysis (N)
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Table 1 Demographic, clinical and psychosocial characteristics of the ESRD study population
Variable Total (n = 458) Predialysis(A) (n = 182) In-centre HD(B) (n = 186) Home HD(C) (n = 90) p-value
Age Mean (std. dev.) 59.84 (13.28) 56.84 (14.78) 51.81 (11.67) p < 0.001a A > C
p < 0.001b B > C
p = 0.017b
Gender Male 296 (64.6 %) 110 (60.4 %) 119 (64.0 %) 67 (74.4 %) p = 0.073c
Education Post high school education 111 (25.1 %) 43 (24.2 %) 31 (17.5 %) 37 (42.5 %) p < 0.001c
A < C p < 0.05d
B < C p < 0.05d
Employment Retired 213 (46.8 %) 94 (51.6 %) 87 (47.3 %) 32 (36.0 %) p < 0.001c
Retired
Unemployed 115 (25.3 %) 31 (17.0 %) 64 (34.8 %) 20 (22.5 %) A > C p < 0.05d
Unemployed
Self-employed 35 (7.7 %) 17 (9.3 %) 10 (5.4 %) 8 (9.0 %) A < B p < 0.05d
Salaried 92 (20.2 %) 40 (22.0 %) 23 (12.5 %) 29 (32.6 %) Salaried
A > B p < 0.05d
C > B p < 0.05d
Ethnicity Non-white 46 (10.1 %) 14 (7.7 %) 20 (10.8 %) 12 (13.3 %) p = 0.32c
BMI (kg/mb) Median (interquartile
range)
28.38 (24.27, 32.45) 26.50 (23.08, 31.51) 26.53 (23.63, 30.83) p = 0.031e
A > B p = 0.040f
A > C p = 0.21f
C > B p = 1.00f
Smoking status Never smoked 257 (56.7 %) 98 (54.1 %) 103 (56.6 %) 56 (62.2 %) p = 0.57c
Ex-smoker 133 (29.4 %) 54 (29.8 %) 53 (29.1 %) 26 (28.9 %)
Current 63 (13.9 %) 29 (16.0 %) 26 (14.3 %) 8 (8.9 %)
Caregiver Spouse/partner 250 (56.2 %) 111 (62.0 %) 83 (46.6 %) 56 (63.6 %) p = 0.004c
Spouse/part
Child carer 24 (5.4 %) 12 (6.7 %) 6 (3.4 %) 6 (6.8 %) A > B p < 0.05d
C > B p < 0.05d
Parent carer 34 (7.6 %) 10 (5.6 %) 16 (9.0 %) 8 (9.1 %) F, R, S or C
Friend, relative, sibling or carer 19 (4.3 %) 3 (1.7 %) 13 (7.3 %) 3 (3.4 %) B > A p < 0.05d
Alone 118 (26.5 %) 43 (24.0 %) 60 (33.7 %) 15 (17.0 %) Alone
B > C p < 0.05d
Marital status Married 253 (55.2 %) 106 (58.2 %) 89 (47.8 %) 58 (64.4 %) p = 0.020c
Married
B < C p < 0.05dPartner 27 (5.9 %) 11 (6.0 %) 10 (5.4 %) 6 (6.7 %)
Single 103 (22.5 %) 38 (20.9 %) 54 (29.0 %) 11 (12.2 %) Single
B > C p < 0.05d
Divorced or separated 40 (8.7 %) 11 (6.0 %) 17 (9.1 %) 12 (13.3 %)
Widowed 35 (7.6 %) 16 (8.8 %) 16 (8.6 %) 3 (3.3 %)
Psych usage Never offered 180 (40.8 %) 70 (38.9 %) 84 (48.8 %) 26 (29.2 %)
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Table 1 Demographic, clinical and psychosocial characteristics of the ESRD study population (Continued)
P < 0.001c
Never offered
B > C p < 0.05d
Never used
A > B p < 0.05d
Used and found useful
C > A p < 0.05d
Used but not useful
C > B p < 0.05d
Never used 209 (47.4 %) 98 (54.4 %) 69 (40.1 %) 42 (47.2 %)
Used and found useful 36 (8.2 %) 6 (3.3 %) 16 (9.3 %) 14 (15.7 %)
Used but not useful 16 (3.6 %) 6 (3.3 %) 3 (1.7 %) 7 (7.9 %)
Primary cause of ESRD Hypertensive Nephrosclerosis 55 (12.0 %) 34 (18.7 %) 12 (6.5 %) 9 (10.0 %) p < 0.001c
Hyp Neph
A > B p < 0.05d
Diabetic Nephropathy 96 (21.0 %) 45 (24.7 %) 42 (22.6 %) 9 (10.0 %) Diab Neph
A > C p < 0.05d
B > C p < 0.05d
Glomerulonephritis 65 (14.2 %) 19 (10.4 %) 30 (16.1 %) 16 (17.8 %) Polycystic KD
C > A p < 0.05d
C > B p < 0.05dPolycystic Kidney Disease 55 (12.0 %) 18 (9.9 %) 18 (9.7 %) 19 (21.1 %)
Renovascular Disease 12 (2.6 %) 4 (2.2 %) 8 (4.3 %) 0 (0 %)
Chronic Pyelonephritis/ Reflux
Nephropathy
29 (6.3 %) 8 (4.4 %) 15 (8.1 %) 6 (6.7 %)
Others 83 (18.1 %) 36 (19.8 %) 32 (17.2 %) 15 (16.7 %)
Unknown 63 (13.8 %) 18 (9.9 %) 29 (15.6 %) 16 (17.8 %)
Yes 121/276
(43.8 %)
~ 83 (44.6 %) 38 (42.2 %)
Hypertension Yes 348 (76.0 %) 152 (83.5 %) 123 (66.1 %) 73 (81.1 %) p < 0.001c
A > B p < 0.05d
C > B p < 0.05d
Diabetes Yes 123 (27.0 %) 56 (30.8 %) 56 (30.4 %) 11 (12.4 %) p = 0.002c
A > C p < 0.05d
B > C p < 0.05d
H/O Anxiety Yes 14 (3.1 %) 5 (2.7 %) 5 (2.7 %) 4 (4.4 %) p = 0.69c
H/O Depression Yes 48 (10.5 %) 17 (9.3 %) 18 (9.7 %) 13 (14.4 %) p = 0.39c
CCI Median (inter-quartile range) 5.00 (3.75, 6.00) 4.00 (3.00, 6.00) 3.50 (2.00, 5.00) p < 0.001e
A > B p = 0.60f
A > C p < 0.001f
B > C p = 0.004f
BDI 0-10 239 (52.2 %) 102 (56.0 %) 91 (48.9 %) 46 (51.1 %) p = 0.783
11-15 73 (15.9 %) 27 (14.8 %) 31 (16.7 %) 15 (16.7 %)
16-20 45 (9.8 %) 18 (9.9 %) 20 (10.8 %) 7 (7.8 %)
21-25 44 (9.6 %) 17 (9.3 %) 20 (10.8 %) 7 (7.8 %)
26-30 25 (5.5 %) 6 (3.3 %) 13 (7.0 %) 6 (6.7 %)
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Table 1 Demographic, clinical and psychosocial characteristics of the ESRD study population (Continued)
≥31 32 (7.0 %) 12 (6.6 %) 11 (5.9 %) 9 (10.0 %)
STAI State 20-29 148 (33.4 %) 54 (30.0 %) 61 (34.5 %) 33 (38.4 %) p = 0.863
30-39 131 (29.6 %) 57 (31.7 %) 53 (29.9 %) 21 (24.4 %)
40-49 100 (22.6 %) 42 (23.3 %) 38 (21.5 %) 20 (23.3 %)
≥50 64 (14.4 %) 27 (15.0 %) 25 (14.1 %) 12 (14.0 %)
STAI Trait 20-29 121 (27.6 %) 47 (26.3 %) 49 (28.2 %) 25 (29.1 %) p = 0.433
30-39 124 (28.2 %) 46 (25.7 %) 54 (31.0 %) 24 (27.9 %)
40-49 111 (25.3 %) 55 (30.7 %) 39 (22.4 %) 17 (19.8 %)
≥50 83 (18.9 %) 31 (17.3 %) 32 (18.4 %) 20 (23.3 %)
TMT A Median (inter-quartile Range) 46.65 (32.25, 60.00) 47.00 (36.00, 69.00) 35.50 (30.00, 47.53) p < 0.001e
B > A p = 0.39f
A > C p = 0.001f
B > C p < 0.001f
TMT B Median (inter-quartile range) 90.00 (68.50, 120.00) 113.00 (73.00, 145.00) 74.00 (61.00, 94.00) p < 0.0015
B > A p = 0.0236
A > C p = 0.0076
B > C p < 0.0016
3MS ≤75 11 (2.6 %) 2 (1.2 %) 8 (4.6 %) 1 (1.3 %) p = 0.0517
76-80 14 (3.3 %) 6 (3.5 %) 6 (3.5 %) 2 (2.6 %)
81-85 35 (8.3 %) 9 (5.3 %) 21 (12.1 %) 5 (6.5 %)
86-93 157 (37.3 %) 64 (37.4 %) 69 (39.9 %) 24 (31.2 %)
94-100 204 (48.5 %) 90 (52.6 %) 69 (39.9 %) 45 (58.4 %)
aANOVA p-value for overall between groups mean differences
bScheffe adjusted p-values for comparison of pair-wise group means
cPearson Chi-Square p-value
dz-test comparing category proportions between groups, p-value with Bonferroni adjustment for multiple testing
eKruskal-Wallis test p-value
fMann-Whitney U test p-value with adjustment for multiple testing
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importance and due to the fact there were differences be-
tween the groups, it was automatically included as a vari-
able in both the API-DM and API-IS analyses. The group
variable being included should therefore account for the
differences in characteristics of the group.
API in ESRD population
We measured the internal consistency of the items in
the API, in our study population using Cronbach’s alpha.
This was acceptable for both information-seeking
(Cronbach’s alpha = 0.774) and decision-making (Cron-
bach’s Alpha = 0.714) subscales of the API. The mean and
standard deviations for all the items in both subscales are
presented in the Additional file 2: supplementary material.
Descriptive data analysis of the two subscales and clinical
vignettes
The median score for the API information-seeking scale
and the API decision-making scale in all three study
cohorts is depicted in box plots (Fig. 2). For the API
clinical vignettes, worsening symptom severity was
associated with a change in treatment decision-making
preference scores, and most patients in the collective
ESRD group wanted shared decision-making with
their healthcare provider if symptoms hypothetically
worsened (Fig. 3).
Demographic, clinical and psychosocial factors predicting
decision-making in ESRD
In the single variable analysis of the information-seeking
subscale scores, the predictors at the 15 % significance
level of high IS scores were (linear regression with just
the variable of interest in the model): age, education,
study group, gender, marital status, heart failure, BDI
score, 3MS, IMD score (index of multiple deprivation),
first choice of dialysis modality and perceived ability to
consider self-cannulation for haemodialysis.
In the single variable analysis of the decision-making
subscale (Table 2), variables significant at the 5 % level
(a linear regression with just the variable of interest in
the model) and were considered for the multivariable
analysis include: age, study group, employment, marital
status, psychology service use, diabetes, heart failure, is-
chaemic heart disease history, CCI, TMT A and API
information-seeking subscale score. Additionally, vari-
ables up to 15 % significance were also included in the
multivariable model. These include gender, ethnicity, in-
formal caregiver availability and patient attendance of a
treatment options education session. The confounder
adjusted analysis has highlighted a number of significant
variables in common with the unadjusted single variable
analysis. The multiple linear regression selection process
for the decision-making subscale (Table 3), which had
Fig. 2 Box Plots showing the median scores on the API for Information-seeking and Decision-making subscales in all three study groups
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age, education and study group adjusted for, selected lower
age, female gender, marital status, API information-seeking
scores and white ethnicity background at 5 % signifi-
cance level, in favour of greater autonomy in
decision-making. Education was not significant in the
multivariable analysis. The multiple linear regression
selection process for the information-seeking scores
(Table 3), which had age, education and study group
adjusted for, selected lower age, post high school edu-
cation, marital status and per category increase in
BDI score at the 5 % significance level as significantly
associated with information-seeking. In the model
where ‘centre-effect’ was evaluated, sensitivity analysis
that suggests very little change for API-DM and for
API-IS education and age are slightly less significant
than in the model without the centre-effect included.
The likelihood ratio test in both cases failed to reject
the null hypothesis of there being no difference
between the mixed effects model and the ordinary
linear model.
‘Autonomists’ vs ‘Delegators’
Decision-making subscale scores were subdivided into
tertiles to identify variables associated with high
(DM > 70: empirically designated as autonomists) and
low DM (≤30: empirically designated as delegators) scores
(Fig. 4). This shows association of higher decision-making
scores with lower age, lower comorbidity index scoring,
higher executive brain function, belonging in the self-
caring cohort and being unemployed (although lack of
employment may have been a conscious decision of the
study participants) (Table 4). Some of these variables sep-
arate the two patient clusters (e.g. CCI, higher cognitive
scores etc.), but these have not featured in the final multi-
variable model involving the total patient cohort, possibly
Fig. 3 Responses to the three clinical vignettes from the API tool by the ESRD group. Actual scores are presented on the x-axis and frequency
distribution of the scores is presented along the y-axis. The responses patients could choose from are provided in the API tool in the Additional
file 3: supplementary material. Vignette 1: Patient preference for management of a simple upper respiratory tract infection (URTI). Median score 6
(Interquartile range 4, 8). Vignette 2: Patient preference for management of high blood pressure (BP). Median score 9 (Interquartile range 7, 11).
Vignette 3: Patient preference for management of a heart attack or acute coronary syndrome (ACS). Median Score 10 (Interquartile range 8, 12)
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Table 2 Single variable analysis and confounder adjusted analysis (Decision-making)
Single Variable Analysis (API-DM) Confounder Adjusted Analysis (API-DM)
Variable of interest EMM*(95 % CI) p-
value
Confounders Regression Coefficient (95 % CI) p-
value
Age (per year)** 71.60-0.37 (−0.48, −0.26) <0.001 Ethnicity, Caregiver, Marital status, Education session,
Psych service use, API-IS, group
−0.33 (−0.48, −0.19) <0.001
Education High school 49.88 (47.96, 51.80) 0.29 Age, ethnicity, psych service use, diabetes, education
session
−2.31(−6.12, 1.50) 0.23
Post high school 51.91 (48.64, 55.19)
Gender Male 49.49 (47.44, 51.53) 0.092 CCI −2.03 (−5.47, 1.41) 0.25
Female 52.45 (49.67, 55.24)
Employment Retired 46.05 (43.69, 48.42) <0.001 Ethnicity, caregiver, marital status, psych service use,
CCI, education session, TMT A
−2.61 (−7.65, 2.42)7.97 (2.63, 13.30)0.04
(−7.47, 7.55)
0.001
Unemployed 57.13 (53.94, 60.32)
Self employed 50.00 (44.25, 55.75)
Salaried 56.63 (49.08, 56.18)
Employed 51.90 (48.79, 55.02)
Ethnicity White 50.90 (49.16, 52.64) 0.13 Age, employment 8.22 (2.86, 13.59) 0.003
Non-white 46.65 (41.50, 51.80)
BMI <25 49.89 (47.08, 52.71) 0.74 Age, gender −2.58 (−6.42, 1.26)−0.06 (−4.05, 3.93) 0.33
25-29.99 50.12 (47.14, 53.09)
≥30 51.37 (48.52, 54.23)
Smoking Status Never smoked 51.19 (48.97, 53.40) 0.65 Age, gender, employment 1.98 (−2.81, 6.76)2.50 (−2.78, 7.79) 0.64
Ex-smoker 49.39 (46.30, 52.48)
Current 50.33 (45.90, 54.77)
Caregiver Spouse or partner 50.31 (48.07, 52.54) 0.12 Employment, psych service use, CCI, group 3.56 (−0.44, 7.55)−2.08 (−9.89, 5.72)1.66
(−5.55, 8.88)3.28 (−5.15, 11.71)
0.33
Child 46.56 (39.26, 53.86)
Parent 57.35 (51.35, 63.36)
Friend, RelativeSibling,
Carer
53.47 (45.22, 61.72)
Alone 49.05 (45.82, 52.27)
Marital Status Married or partner 51.22 (49.12, 53.31) 0.006 Age, employment, psych service use,TMT A, group 7.88 (1.51, 14.25)3.95 (−3.40, 11.31)4.29
(−3.95, 12.53)
0.041
Single 51.86 (48.44, 55.28)
Divorced or separated 51.28 (45.73, 56.84)
Widowed 40.36 (34.49, 46.22)
Psych service use Not used 49.75 (47.96, 51.54) 0.088 Age, employment, caregiver, marital status,
diabetes,TMT A, group
0.56 (−5.13, 6.24) 0.85
Used 54.25 (49.40, 59.09)
Diabetes No 51.63 (49.70, 53.55) 0.021 Age, employment, psych service use 2.75 (−0.95, 6.46) 0.14
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Table 2 Single variable analysis and confounder adjusted analysis (Decision-making) (Continued)
Yes 47.21 (43.99, 50.43)
Heart Failure No 50.91 (49.23, 52.60) 0.042 Age 5.61 (−1.76, 12.99) 0.14
Yes 42.99 (35.54, 50.44)
IHD No 51.51 (49.64, 53.39) 0.032 Age, gender, employment, diabetes, TMT A −0.50 (−4.68, 3.68) 0.81
Yes 47.24 (43.81, 50.66)
Stroke No 50.79 (49.07, 52.51) 0.28 Age, IHD, education session −0.05 (−6.13, 6.04) 0.99
Yes 47.38 (41.46, 53.31)
Solid Organ
Malignancy
No 50.26 (48.51, 52.01) 0.36 Age, employment, caregiver, psych service use,
diabetes, group
−2.71 (−8.09, 2.67) 0.32
Yes 52.78 (47.72, 57.84)
Charlson Comorbidity Index (per unit)** 60.67−2.26 (−3.07, −1.44) <0.001 Gender, ethnicity, caregiver, marital status, psych
service use, education session
−1.87 (−2.79, −0.96) <0.001
BDI in 6 categories(per category) –low
score to high score**
49.200.60 (−0.43, 1.63) 0.25 Age, employment, diabetes, API IS −0.28 (−1.33, 0.77) 0.61
Anxiety State in 4 categories(per category)
–low score to high score**
49.560.47 (−1.14, 2.08) 0.56 Age, employment, ethnicity, marital status −0.35 (−1.92, 1.22) 0.66
Anxiety Trait in 4 categories(per category) –
low score to high score**
48.550.82 (−0.75, 2.38) 0.31 Employment,ethnicity, marital status,CCI, API IS −0.60 (−2.18, 0.98) 0.46
3MS in 5 categories(per category) –high
score to low score**
51.64−0.63 (−2.49, 1.22) 0.50 Age, employment, diabetes, IHD, TMT A 0.98 (−1.03, 2.99) 0.31
Options education
session
No 51.29 (49.40, 53.18) 0.11 Age, employment, group 0.11 (−3.73, 3.96) 0.95
Yes 48.13 (44.77, 51.48)
Predialysis
education
experience
Very poor/Not useful/
Inadequate
52.53 (46.56, 58.49) 0.18 Employment, caregiver, marital status, psych service
use, education session, group
1.95 (−4.91, 8.80)1.58 (−2.30, 5.45) 0.69
Good 50.72 (48.03, 53.40)
Excellent 47.62 (44.79, 50.45)
TMT A (per unit)** 54.21−0.07 (−0.13, −0.01) 0.018 Age, marital status, psych service use, diabetes, IHD −0.01 (−0.07, 0.05) 0.78
TMT B (per unit)**Δ 54.08−0.02 (−0.06, 0.01) 0.22 Age, ethnicity, marital status, psych service use,
diabetes,IHD, TMT A
— —
API IS Per percentage
increase
26.560.30 (0.15, 0.44) <0.001 Age, group 0.19 (0.04, 0.33) 0.010
Group PredialysisHospitalSelf-
care
45.88(43.32, 48.44)51.96 (49.43,
54.48)56.81 (53.20, 60.41)
<0.001 Age, caregiver, marital status, psych service use,
diabetes, education session, TMT A, API IS
−7.09 (−12.09, −2.09)−1.76 (−6.82, 3.29) 0.006
*Estimated Marginal Mean
**The results for these continuous variables are presented as the intercept, the parameter estimate and the 95 % CI of the parameter estimate
Δ Analysis not reported as >25 % missing values in the dataset
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due to differences being most extreme at very high and
very low scores.
Decision-making in a prospective observation of the
subset of dialysis starters
Complete API data on dialysis starters was available from
30 predialysis patients who commenced dialysis during
the follow-up period up to 1 year from study entry. The
data was completed at least 3 months after commence-
ment of dialysis. The mean (SD) decision-making percent-
age score after commencement of dialysis was 37.79
(16.45), which was not significantly different from the
predialysis mean (SD) of 40.52(11.73).
Table 3 Multivariable Analysis (Age, education and group included a priori)
MULTIVARIABLE LINEAR REGRESSION ANALYSIS: DECISION-MAKING SUBSCALE
Variable Parameter estimate (95 % CI) p-value
Education High school −1.23 (−4.83, 2.36) 0.50
Post high school ~
Group Predialysis −8.20 (−12.59, −3.81) <0.001
In-centre HD −1.68 (−6.05, 2.68)
Home HD ~
Gender Male −3.29 (−6.52, −0.07) 0.046
Female ~
Marital Status Married or Partner 8.79 (2.92, 14.65) 0.015
Single 5.43 (−1.35, 12.21)
Divorced/Separated 6.26 (−1.28, 13.80)
Widowed ~
Age (per 10 years) −3.27 (−4.54, −2.01) <0.001
Ethnicity White 10.62 (5.36, 15.89) <0.001
Non-white ~
API (Information Seeking %) Per percentage increase 0.15 (0.01, 0.30) 0.035
Between-centre variability 1.17 X 10−19 (1.05 X 10−36, 0.01) -
Within-centre variability 253.25 (221.53, 289.52) -
Intra Class Coefficient (ICC)*** 4.61 X 10−22 (−)** -
MULTIVARIABLE LINEAR REGRESSION ANALYSIS: INFORMATION-SEEKING SUBSCALE
Variable Parameter estimate (95 % CI) p-value
Education High school −2.06 (−4.41, 0.28) 0.085
Post high school ~
Cohort Predialysis −4.16 (−6.99, −1.33) <0.001
In-centre HD −0.20 (−3.05, 2.64)
Home HD ~
Marital status Married or partner 1.84 (−1.96, 5.65) 0.002
Single −2.56 (−6.96, 1.83)
Divorced or sep. 4.14 (−0.75, 9.04)
Widowed ~
Age (per 10 years) −0.79 (−1.60, 0.03) 0.058
BDI in 6 categories (per category increase)* 0.86 (0.24, 1.49) 0.007
Between-centre variability 1.14 (0.08, 16.36) -
Within-centre variability 107.87 (94.40, 123.27) -
Intra Class Coefficient (ICC)*** 0.01 (7.28 X 10−4, 0.13) -
*BDI categories: 0–10, 11–15, 16–20, 21–25, 26–30, ≥31
**Standard error estimate of ICC very close to 0 so no confidence interval provided
***ICC is a measure of the correlation of observations in the same cluster. ICC close to 1 indicates the people in the cluster are very similar, whereas ICC close to 0
indicates the between cluster variability is small compared to the within cluster variability
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Fig 4 Distribution of patient clusters determined by high and low decision-making scores
Table 4 Cluster associations with demographic, clinical and psychosocial variables
Variable 1(Delegators) (n = 57) 3(Autonomists) (n = 66) p-value
Group
Predialysis 30 (52.6 %) 15 (22.7 %) <0.001b
Hospital 19 (33.3 %) 27 (40.9 %)
Home 8 (14.0 %) 24 (36.4 %)
Age- Median (IQR) 67.0 (56.0-71.5) 52.0 (42.8-63.0) <0.001a
Employment
Retired 39 (68.4 %) 22 (33.3 %) <0.001b
Unemployed 6 (10.5 %) 24 (36.4 %)
Self-employed 4 (7.0 %) 4 (6.1 %)
Salaried 8 (14.0 %) 16 (24.2 %)
Marital Status
Married or partner 34 (59.6 %) 43 (65.2 %) 0.051b
Single 9 (15.8 %) 15 (22.7 %)
Divorced or separated 4 (7.0 %) 6 (9.1 %)
Widowed 10 (17.5 %) 2 (3.0 %)
CCI*
Median (IQR)
n = 56
5.0 (4.0-7.0)
n = 62
3.0 (2.8-5.0)
<0.001a
TMT A
Median (IQR)
n = 56
49.0 (38.0-61.5)
n = 64
37.5 (30.5-52.3)
0.008a
TMT B
Median (IQR)
n = 43
105.0 (84.0-137.0)
n = 54
72.0 (59.0-122.5)
0.007a
IS score
Median (IQR)
n = 57
84.38(75.00-90.63)
n = 66
93.75(81.25-100)
<0.001a
*CCI: Charlson Comorbidity Index
aMann-Whitney U test p-value
bFisher’s exact test p-value
Note: A sensitivity analyses was carried out with cut-off scores for the API-DM subscale for patient subgroups at 25/75 and at 35/65.The significant variable out-
comes across all these analyses are comparable (Additional file 3: supplementary material provided)
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Discussion
Clinical outcomes associated with RRT modalities are
different. The challenge with interpreting reported out-
comes on modality superiority are the sociodemo-
graphic, physiological and psychological differences
which exist between patients in different treatment
groups, and the change over time in some of these fac-
tors. The systematic exclusion, through lack of informa-
tion of patient’s values, preferences and engagement,
leading to the choice (or the lack of one) of modality
may also have a bearing on the desired outcomes. In our
study of patient preferences for autonomous decision-
making in ESRD management, we have a large, repre-
sentative sample population, including predialysis pa-
tients in the process of modality decision-making and
patients established on ‘in-centre’ and ‘self-care’(predo-
minantly home-based) haemodialysis, from across five
tertiary centres. To our knowledge, this is the first study
which has examined the issue of patient preferences for
information-seeking and decision-making in an ESRD
population preparing to receive dialysis and that in re-
ceipt of haemodialysis therapy, simultaneously. We have
also examined longitudinally, if DM preference in pre-
dialysis patients changes over time in a subset of pa-
tients, after commencement of dialysis therapy. The
variables considered for analyses have been categorised
in a manner meaningful for clinical interpretation. These
apply especially to neuropsychometric tests and depres-
sion and anxiety screening tools where use of cut-off
points may result in loss of information to be ascer-
tained from scores further removed from the cut off
mark. The coefficient of internal consistency of the two
subscales of API is high, ensuring reliability of the test
findings in our study population.
In a separate study by Flynn et al.[24], cluster analysis
was used to understand the typology of patient prefer-
ences in a large group of older adults. The vast majority
of them wanted information exchange, but differed in
preferences for discussing and selecting treatment
choices based on deliberation and decisional control.
This study highlighted the need for strategies to improve
information exchange and distinguish preferences for
discussing and selecting treatment options. Our study
has taken the understanding of the subject to individuals
who are on a declining health course, those in receipt of
different treatment types, respondents in varied sociode-
mographic groups and considered varied cognitive and
psycho-affective factors which may also influence the ac-
tual response outcomes.
Demographic variables and patient preference for
decision-making in ESRD
Age is an important factor in decision-making prefer-
ence, with younger age group preferring a more active
role in decision-making. Despite the fact that older pa-
tients wanted less participation in treatment decision-
making, they nonetheless wanted a similar degree of in-
formation (high overall median scores on information-
seeking subscale), demonstrating that wanting informa-
tion and making decisions are separate constructs[25].
Even amongst the study cohort of high information-
seekers overall, age still emerged as a significant factor
for both information-seeking and decision-making, with
high scores in favour of lower age. Higher confidence,
greater overall perceived knowledge, greater overall
retained information/knowledge and access to modern
educational resources (internet), consulted by the youn-
ger population may play a role, in this regard. Besides,
the type of information required by the older age group
and the manner in which information is provided to
older patients may have to be tailored to individual pref-
erences, such that, their engagement with the decision-
making process is well facilitated and meaningful.
Higher education, like age, was forced into our model
for multivariate regression analysis and did emerge as a
significant variable for information-seeking, but not for
decision-making. This highlights the role of the individ-
ual’s coping style and the complexity of ESRD decision-
making process, making collaborative decision-making, a
preferred route even amongst those who are well edu-
cated and actively seek involvement through informa-
tion. Even in the cluster examination of ‘autonomists’ vs
‘delegators’, education, was not associated with either
category. This is contrary to what has been noted in
some other conditions where API was used to study
decision-making preference [26–28] and also in other
qualitative research in the area of medical decision-
making[29]. Several studies have identified that gender is
associated with DM preference, all finding that women
are more likely than men to prefer a more active
role[30]. This finding has been replicated in our ESRD
study population too, although another observational
study in ESRD patients, did not find significant gender
differences, although a smaller study population may ex-
plain this [31]. The role of gender and the biology of
decision-making remains an interesting area of research,
but, the influence of gender on interpersonal relationship
between the physician and the patient may influence par-
ticipatory decision-making styles [32]. Employment is not
a significant predictor on multivariate analysis, but re-
mains a significant association in the cluster of low
decision-making scorers. This is likely to be due to the fact
that the employment variable is very closely linked to the
‘cohort’ variable, which was a significant predictor on the
regression analysis. The cluster association showed that
‘retired’ individuals were more likely to assume a passive
role in decision-making. Significantly higher proportion
(37 %) of unemployed participants were found in the
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‘autonomists’ group, although the decision to stay un-
employed may have been taken consciously by this group.
Marital status also seems to influence decision-making
preference, with married individuals more likely than un-
married, divorced or widowed participants to play an ac-
tive role in decision-making. Ethnicity is associated with
DM in our study, with white patients more likely to prefer
to be involved in decision-making. Patient’s role expecta-
tions, perceived role in the family context and emphasis on
individuality may be a culturally determined phenomenon,
influencing the passive role adopted by participants in the
ethnic minority group [33]. The approach to imparting in-
formation and ascertaining patient’s values and preferences
should be culturally sensitive and account for the cultural
diversity of different regions.
Cognitive function and decision-making preference in ESRD
We examined the association of scores from Trail mak-
ing tests A and B and 3MS, a test of global cognition,
with decision-making preference scores. The lowest ter-
tile of decision-making scores was associated with
poorer scores on the tests of executive brain function.
Although this was not significant in the multivariate re-
gression analysis, TMT A scores were significant on sin-
gle variable analysis. This is likely due to a significant
proportion of missing data on TMTs, largely due to pa-
tients’ inability to complete tests or unwillingness to
undertake the tests due to perceived complexity. There
is evidence from literature linking age, cognition and
other individual resources with health literacy in ad-
vanced age[12]. Results show that executive function
and episodic memory explained literacy decline with age
considerably. Executive function also had an indirect ef-
fect via risk aversion. The finding that impaired health
literacy in old age is in part a function of cognitive de-
cline even amongst persons without dementia, has clear
implications for policy and intervention. Thus, it is high
priority to reduce cognitive demands, particularly com-
plex reasoning abilities and memory, inherent in the
health literature materials and decision-making aids
used by patients with even milder degrees of cognitive
impairment. Learning styles specific information and
reinforcement of consistent messages will ensure
correct understanding. Impact of depression on DM
was not significant in our study, but higher BDI scores
were significantly associated with higher information-
seeking. The ability to appreciate, understand the sig-
nificance, express choice or engage in a logical process
of analysing the information ascertained are known to
be impaired in depressed patients in other studies [34].
Illness burden and decision-making preference in ESRD
None of the comorbidities emerged significant predic-
tors of decision-making in the multivariate analysis.
However, the Charlson comorbidity index score, a prog-
nostic tool, was significant in the univariate analysis, and
so were, diabetes, heart failure and ischaemic heart dis-
ease. In the cluster examination, the lowest tertile of
decision-making scores was associated significantly with
high comorbidity burden. The impact of illness on
decision-making is difficult to dissociate from the role of
medical care received for the illness on decision-making.
Results from studies in published literature suggest that
patient’s preference may change in time as their experi-
ence of illness evolves [35] and that, experiences of in-
teractions with healthcare providers may also affect
patient’s desire to involve themselves in current or future
decision-making[26]. It is apparent from our study that
in the small subset of predialysis patients, who were re-
assessed at least three months after commencement of
dialysis therapy, no significant change in their decision-
making preferences, was observed. It is also apparent
that the more complex or urgent the clinical condition,
the more likely ESRD patients would consider adopting
a more passive role.
Information preference and study group influence
Our study demonstrates that there is great appetite for
information across all study groups. Even amongst the
high information-seekers, API information-seeking score
greater than 75, is associated significantly with greater
preference for decision-making. The scores are signifi-
cantly higher in the self-caring cohort and this may well
be associated with an active coping style, the same group
demonstrating higher preference for involvement in
decision-making. The predialysis group was more likely
to want shared involvement in the decision-making
process compared to other groups in the multivariate
analysis and cluster association of low decision-makers.
The lack of concrete, personal experience of the treat-
ment process may be the reason for their concern.
Therefore, revisiting treatment options after commence-
ment of dialysis may influence the choice of long-term
dialysis treatment considerations including location and
self vs shared vs institutional care.
Links with medical humanities and social sciences
The study findings are well in line with predictions
drawn from established theories in social psychology.
For instance, decision fatigue [36]is a psychological state,
where the ability to process complex information and to
make autonomous decisions is depleted due to e.g. emo-
tional upheaval, resulting in impulsiveness, evasive be-
haviour or helplessness. The effects of illness burden on
decision-making preference in ESRD can be seen correl-
ating with both decision fatigue and emotional adjust-
ment[37, 38]: a patient who has been only recently
diagnosed with a severe illness is emotionally and
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cognitively handicapped due to mental fatigue, in com-
parison to a patient who has had time to process the
emotional upheaval and adjust. Recent developments in
the psychology of decision-making have revealed several
factors influencing and distorting the ability to make au-
tonomous, well-informed decisions, of which decision
fatigue is only one. To facilitate patient autonomy in
various stages of emotional adjustment and levels of fa-
tigue, procedures including psychological support and
appropriate information design become necessary to en-
sure the fulfillment of patient autonomy.
Practical implications of the knowledge of patient’s
decision-making preference
It is known from published literature that patients who
are educated about all of their treatment options are sig-
nificantly more likely to choose a home-based treatment
option [39–41]. Information empowers patients to
choose their RRT modality. The manner in which this
information is presented therefore would influence the
patients’ choice of therapy. Many decisions of this com-
plexity may well result in a shift in decision-making
equipoise, making patient-led autonomous decisions, a
function, limited by three key factors-patient characteris-
tics, time constraints and clinical urgency. It is apparent
from our study that subsets of well-informed patients
are still keen on involving the healthcare team in their
decision-making process. There are patient characteris-
tics which influence their wish to be involved in
decision-making. These become apparent as the clinical
encounter progresses over time. The reasons behind
delegating the choice to another person need to be ex-
plored at a clinical and psychosociocultural level through
collaborative decision-making, engaging patients, their
family, and several members of the multi-disciplinary
care team. This process typically operates in consider-
able time constraints, making a truly autonomous deci-
sion or shared decision-making by patient choice, an
option for a limited few. The third point on clinical ur-
gency is a situation where patients naturally lean to-
wards their physician in making the right choices for
them. Presenting all dialysis options as equal with the
healthcare team remaining modality neutral (and there-
fore presumed unbiased), without clarifying the impact of
each choice on the course of their illness, associated mor-
bidity, mortality and quality-of-life, renders modality
education practice unchanged and unresponsive to pub-
lished scientific literature. Furthermore, patient’s decision-
making preferences ought to be juxtaposed to the system-
atic assessment of patients’ affect and cognitive abilities
and actual as against perceived knowledge. These remain
integral to understanding the level and duration of health-
care provider engagement required to facilitate literacy
and the decision process.
Study limitations
There are limitations to our study. Assessing healthcare
provider’s decision-making preferences would be import-
ant as decision-making happens during this bidirectional
exchange of information. Assessment of actual know-
ledge as a predictor of decision-making preference
would be useful. Although a number of clinical, psycho-
logical and socio-demographic variables have been con-
sidered, autonomy preference in a medical context is
likely to be influenced by immeasurable factors and
therefore our findings do not necessarily present an ex-
haustive list of predictors of autonomy preference in
ESRD or explain the variance in autonomy preference. It
is also not possible to ascertain from our study if pre-
ferred participation differs from actual participation
levels when removed from hypothetical scenarios.
Conclusions
The study explored decision-making preferences and its
influencing factors in ESRD patients overall and accord-
ing to their position with respect to dialysis commence-
ment. ESRD patients prefer to receive information, but
this does not always translate into active involvement in
decision-making. This may not be acceptable or appro-
priate for everyone and the patient may choose to deter-
mine the extent to which they seek involvement. By
identifying factors which might affect patient preference
for involvement, health professionals may move away
from a normative, ‘one size fits all’ approach, be more
sensitive to individual patient’s preferences and provide
better patient-centred; individual-appropriate care.
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